Clinical Trial Update: Women's Estrogen for Stroke Trial (WEST) [Phase 3]

View source ↗

Summary

The Phase 3 Women's Estrogen for Stroke Trial (WEST) has completed. The trial investigated estrogen therapy for stroke in women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Estrogen therapy (estradiol)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Stroke | Phase 3 | Status: COMPLETED